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Case report
A 41-year-old femalewith known stage IVBmoderately differentiat-
ed squamous cell carcinoma of the cervix presented with one month of
progressive pain and swelling of her left fourth metatarsal. She was
initially diagnosed ﬁve months prior, symptomatic with four months
of persistent cough, decreased appetite, weight loss, and night
sweats. She denied abnormal bleeding or discharge and had never
received cervical cancer screening. On physical examination, her cer-
vix was obliterated by a large irregular mass involving the anterior
and upper vagina, recto-vaginal septum, and bilateral pelvic side-mous cell carcinoma of the cervix. Systemic computed tomographyBackground
Cervical cancer is locally invasive, spreading primarily through
direct extension. Lymphatic spread to regional pelvic nodes is less
common, and hematogenous spread occurs even less frequently,
often occurring in advanced stages of cervical cancer with high
grade tumors that is responsible for metastases to lungs, liver,
spleen, brain, and bone (Agarwal et al., 2002). Accordingly, bone me-
tastases most commonly involve direct and lymphatic spread to the
pelvis and lumbar spine (Dewdney and Selvarajah, 2010). Distal ap-
pendicular skeletal metastases, attributable to hematogenous dis-
ease dissemination, are rare.
Here, we report two cases of squamous cell carcinoma of the cervix
metastatic to the toe, causing pain, edema, and erythema, symptoms
which can mimic infectious etiology. Because toe metastases are rare,
both cases were initially thought to be of infectious origin, highlighting
the importance of awareness of this site of metastases.ology, Department of Obstetrics
iversity of Southern California,
. Fax: +1 323 226 3427.
. Open access under CC BY-NC-ND license. walls. Biopsy of the mass conﬁrmed moderately differentiated squa-
imaging revealed extensive metastases to the chest, abdomen, and
pelvis, including bilateral pulmonary nodules, mediastinal and retro-
peritoneal lymphadenopathy, and a lytic lesion of the pubic symphy-
sis. Due to the distant metastases, she received nine total cycles of
systemic cytotoxic chemotherapy (a combination of cisplatin and
gemcitabine) with temporal response and symptomatic improve-
ment after the ﬁrst six cycles.
During the course of chemotherapy, she reported approximately
a month of pain and swelling in her left fourth toe, which she
noticed while trimming her nails. She denied traumatic injury or
insect bites to her feet or toes. On physical examination, the distal
portion of her left fourth toe was erythematous, enlarged, and
tender to palpation, without proximal extension (Fig. 1A–B). There
was no open wound, ﬂuctuation, or drainage, and she was afebrile
without leukocytosis (white blood cell count, 4.400/m3). Her
symptoms were initially thought to be attributed to infection, and
she was treated with trimethoprim and sulfamethoxazole.
On return visit four weeks later, her symptoms had not abated.
She was also found to have hypercalcemia (14.0 mg/dL), and repeat
systemic imaging following cycle nine showed increasing size of her
primary mass and metastatic disease. She was admitted for treat-
ment of hypercalcemia and workup of her podiatric symptoms. Inci-
sion and drainagewas attempted and failed to demonstrate evidence
of an infectious source. Radiographic evaluation of the foot revealed
erosion and resorption in the fourth distal phalanx with extensive
soft tissue edema (Fig. 1C).
The patient desired toe amputation due to pain and inability to wear
shoes. She underwent an uncomplicated toe amputation, and histological
evaluation revealed metastatic squamous cell carcinoma to the distal
phalanx (Fig. 1D). One week later, the patient's status deteriorated, and
Fig. 1. Images of cervical cancer toe metastasis in Case 1. A) Dorsum of left fourth toe,
notable for profuse swelling, erythema, and necrosis of the distal phalanx. B) Lateral
viewof the same toe. C) Plainﬁlmof the left foot, showing soft tissue swellingwith erosion
and resorption of the fourth distal phalanx. D) Hematoxylin and eosin staining of the toe
following amputation, showing nests of metastatic squamous carcinoma, with necrosis,
in a ﬁbrous stroma, inﬁltrating the marrow space of the distal phalanx.
Fig. 2. Images of cervical cancer toe metastasis in Case 2. A) Dorsum of the left ﬁrst toe,
showing diffuse erythema, scaling, and necrosis. B) Lateral view of the same toe. C) X-ray
of the left foot, showing diffuse sclerosis of the ﬁrst distal phalanxwith soft tissue swelling.
D) Hematoxylin and eosin staining of the toe following amputation, showing nests of
tumor cells occupying the marrow space of the distal phalanx and invading into the
bone trabeculae.
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seven months after initial diagnosis of cervical cancer, and two months
after presenting with toe metastasis.
Case 2
A 27-year-old female with history of stage IB2 poorly differentiated
squamous cell carcinoma of the cervix presented to the emergency
room with symptoms of pneumonia accompanied by progressive pain,
swelling, and erythema of the left ﬁrst metatarsal. She was diagnosed
with cancer two years prior, presenting with heavy vaginal bleeding,
anemia, and a 6 cm cervical mass. Biopsy of the mass showed poorly
differentiated squamous cell carcinoma. She received concurrent
whole pelvis chemo-radiotherapy but prior to completing treatment
(37.8 out of 50.4 Gy received) was lost to follow-up for 9 months.
Upon resumption of care, systemic imaging showed nodal and pancre-
atic metastases. After further systemic chemotherapy with six cycles
of cisplatin and gemcitabine and resolution of extra-uterine disease, the
patient underwent a type III radical hysterectomy, bilateral salpingo-
oophorectomy and pelvic lymphadenectomy. Pathology workup
showed tumor inﬁltration to the parametria and a close vaginal margin.
She was then lost to follow up again, foregoing planned brachytherapy.
Eight months later, she re-presented with the aforementioned respira-
tory and podiatric symptoms. On examination, she was febrile (38.2 °C),
hypoxic, tachypneic, and tachycardic, but had no leukocytosis (white
blood cell count, 5.800/m3). Chest imaging revealed areas of consolida-
tion with extensive mediastinal and hilar adenopathy, compressing theleft bronchial tree and resulting in post-obstructive pneumonia, which
subsequently resolved with broad-spectrum antibiotics.
Regarding her toe, she reported two months of progressive redness
and discoloration beginning at the proximal nail fold, and an inability
to bear weight on the involved toe. On physical examination, her left
hallux was erythematous, enlarged, and necrotic-appearing, with
areas of purple and black discoloration around the nail (Fig. 2A–B). It
was extremely tender to palpation, but without ﬂuctuation. Also noted
were hyperpigmented, plaque-like areas of thickened skin along the
left pre-tibial surface, measuring 1–2 cm in diameter. Radiographic im-
aging showed increased soft tissue density and swelling with sclerosis
around the distal phalanx (Fig. 2C). Trans-dermal punch biopsy of the
toe revealed metastatic squamous cell carcinoma. She underwent palli-
ative amputation of the left ﬁrst toe, and histology conﬁrmedmetastatic
cervical cancer with invasion into the bone, soft tissue, and dermis
(Fig. 2D). Prior to discharge, she was found to have brain metastasis
and expired one month after admission.Discussion
Our cases highlight a key feature of the spreading pattern of cervical
cancer. Clinicians need to be aware that cervical cancer dissemination
sites include the toes. The rate of osseous metastases in cervical cancer
has been quoted to be between 0.8 and 23%, usually occurring in poorly
differentiated tumors, at advanced stage, and with recurrent disease
(Matsuyama et al., 1989; Ratanatharathorn et al., 1994). Variations in
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with higher rates cited in studies utilizing autopsy ﬁndings than those
detected during routine symptom-based workup. In one study of cervi-
cal cancer patients, 69% of bonemetastaseswere only detected at autop-
sy (Abdul-Karim et al., 1990). Furthermore, when spread to bone was
detected, patients often had extensive metastatic disease, as in our
cases.
The most common sites of bony metastases include the vertebral
column, speciﬁcally the lumbar spine, followed by the pelvic bones,
with the distal appendicular skeleton being a distant third. Metatarsal
metastases are so uncommon that only one other source mentions
them (Blythe et al., 1975). Our experienced cases are valuable because
they show the natural course of cervical cancer in patients with toeme-
tastases. Spread to bone is thought to occur via four different methods:
(i) direct extension from the primary or recurrent tumor mass in the
pelvis, often accounting for spread to pelvic bones; (ii) direct extension
from parenchymal and lymph node metastases, such as from the para-
aortic nodes to the spine or from lungsmetastases to the ribs or sternum;
(iii) regional hematogenous metastases, classically spinal metastases
arising from spread through Batson plexus; and (iv) systemic hematog-
enous metastases, accounting for metastases to distant bones, and likely
the mechanism of spread in our cases (Dewdney and Selvarajah, 2010;
Ratanatharathorn et al., 1994). The universal presenting symptom of
these osteolytic lesions is bone pain, with occasionally associated patho-
logic fracture (Blythe et al., 1975). Imaging with X-ray and magnetic
resonance imaging show osteolytic lesions, often adding osteomyelitis
to the differential diagnosis (Dewdney and Selvarajah, 2010; Pasricha
et al., 2006). Biopsy or amputation, however, proves otherwise. If any
of these symptoms present, providers should have a high suspicion for
bony metastases and a low threshold to order plain X-ray imaging.
More systemic imaging such as bone scan or PET–CT will follow if plain
imaging suspects bony metastases.
Both of the two patients received suboptimal treatment for the pri-
mary cervical tumor. For Case 1, palliative pelvic radiotherapy was not
given due to distant metastases and absence of pelvic symptoms. For
Case 2, the patient did not follow the radiotherapy plan and received
only 75% of the scheduled dose. Therefore, these suboptimal treatments
for the primary cervical tumor may contribute to more extensive meta-
static disease as experienced in these cases. In addition, both of the
patients received cisplatin and gemcitabine for the treatment of meta-
static cervical cancer with squamous histology. Given the results of a
recent clinical trial, cisplatin and paclitaxel is an alternative regimen of
chemotherapy treatment (Monk et al., 2009).
Treatment options for toe metastases include palliative resection,
radiation, and systemic chemotherapy, but it is important to assess the
patient's prognosis prior to offering further treatment. Distant bonemetastases are frequently seen in conjunction with multiple soft tissue
metastases, likely representing diffuse hematogenous spread (Blythe
et al., 1975). Since the lungs are the most common site of blood-borne
metastases, they are often already involved by the time metastases to
distal bones are discovered, frequently resulting in death from pulmo-
nary insufﬁciency (Matsuyama et al., 1989). Furthermore, 75–80% of
patients die within one year of diagnosis with osseous metastases
(Matsuyama et al., 1989; Ratanatharathorn et al., 1994). The cases
presented above corroborate these results, as both patients underwent
rapid decompensation and death within a few months of podiatric
symptom onset. Both suffered from pulmonary involvement and one
from brain metastases. In our literature review, only one case study
described a cervical cancer patient with over four years of disease-free
survival following resection of an isolated ﬁbular metastasis (Pasricha
et al., 2006). The role of radiotherapy to treat toe metastasis has not
yet been proven. There were only a few cases reported in the literature,
and all cases including ours underwent surgical resection. However,
radiotherapy may be a possible option if an early diagnosis could be
made without amputation. We conclude that metatarsal metastases in
cervical cancer are usually a symptom of widespread hematogenous
dissemination and thus exceedingly poor prognostic indicators. Treat-
ment should be directed at maximizing quality of life and at providing
palliation for pain using the aforementioned treatment modalities.Conﬂict of interest statement
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